论文信息 - Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). - 字舞流文

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).

E. Wattel | H. Rahimi | A. Shirdel | H. Rafatpanah | M. Mahmoudi | H. de Thé | A. Bazarbachi | O. Hermine | M. Maleki | H. Hajj | H. Thé | M. T. Yazdi | H. El Hajj | S. Rezaee | Reza S. Farid | G. Kchour | H. Hatoum | M. Tarhini | M. Kooshyar | S. A. Rezaee | Mojtaba Tabatabaei Yazdi | Hiba El Hajj